8 million shares, so the reaction is roughly proportional. However, since one reason the stcok is this low to begin with is that they have limited cash, I don't think the upside of gaining more solvent time has been factored in by the market.

But really, none of that matters. Look at HGSI for example. All that matters in the case of CGEN is market sentiment regarding the value of their science. And looking at their growing list of patents, and the diversity of that list, I have to go back to my basic position on this stock: Who cares if the price goes down? If it goes low enough, I'll just add to my position, that's all.